The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Guaifenesin (API) Market Research Report 2024
Synopsis
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global Guaifenesin (API) market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 98.3 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.
This report aims to provide a comprehensive presentation of the global market for Guaifenesin (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guaifenesin (API).
Report Scope
The Guaifenesin (API) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guaifenesin (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guaifenesin (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Segment by Type
98%-99%
Above 99%
Segment by Application
Pharmaceuticals
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Guaifenesin (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Guaifenesin (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global Guaifenesin (API) market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 98.3 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.
This report aims to provide a comprehensive presentation of the global market for Guaifenesin (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guaifenesin (API).
Report Scope
The Guaifenesin (API) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Guaifenesin (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guaifenesin (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Segment by Type
98%-99%
Above 99%
Segment by Application
Pharmaceuticals
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Guaifenesin (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Guaifenesin (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Guaifenesin (API) Market Overview
1.1 Product Overview and Scope of Guaifenesin (API)
1.2 Guaifenesin (API) Segment by Type
1.2.1 Global Guaifenesin (API) Market Value Comparison by Type (2024-2030)
1.2.2 98%-99%
1.2.3 Above 99%
1.3 Guaifenesin (API) Segment by Application
1.3.1 Global Guaifenesin (API) Market Value by Application: (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Guaifenesin (API) Market Size Estimates and Forecasts
1.4.1 Global Guaifenesin (API) Revenue 2019-2030
1.4.2 Global Guaifenesin (API) Sales 2019-2030
1.4.3 Global Guaifenesin (API) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Guaifenesin (API) Market Competition by Manufacturers
2.1 Global Guaifenesin (API) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Guaifenesin (API) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Guaifenesin (API) Average Price by Manufacturers (2019-2024)
2.4 Global Guaifenesin (API) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Guaifenesin (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Guaifenesin (API), Product Type & Application
2.7 Guaifenesin (API) Market Competitive Situation and Trends
2.7.1 Guaifenesin (API) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Guaifenesin (API) Players Market Share by Revenue
2.7.3 Global Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Guaifenesin (API) Retrospective Market Scenario by Region
3.1 Global Guaifenesin (API) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Guaifenesin (API) Global Guaifenesin (API) Sales by Region: 2019-2030
3.2.1 Global Guaifenesin (API) Sales by Region: 2019-2024
3.2.2 Global Guaifenesin (API) Sales by Region: 2025-2030
3.3 Global Guaifenesin (API) Global Guaifenesin (API) Revenue by Region: 2019-2030
3.3.1 Global Guaifenesin (API) Revenue by Region: 2019-2024
3.3.2 Global Guaifenesin (API) Revenue by Region: 2025-2030
3.4 North America Guaifenesin (API) Market Facts & Figures by Country
3.4.1 North America Guaifenesin (API) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Guaifenesin (API) Sales by Country (2019-2030)
3.4.3 North America Guaifenesin (API) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Guaifenesin (API) Market Facts & Figures by Country
3.5.1 Europe Guaifenesin (API) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Guaifenesin (API) Sales by Country (2019-2030)
3.5.3 Europe Guaifenesin (API) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Guaifenesin (API) Market Facts & Figures by Country
3.6.1 Asia Pacific Guaifenesin (API) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Guaifenesin (API) Sales by Country (2019-2030)
3.6.3 Asia Pacific Guaifenesin (API) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Guaifenesin (API) Market Facts & Figures by Country
3.7.1 Latin America Guaifenesin (API) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Guaifenesin (API) Sales by Country (2019-2030)
3.7.3 Latin America Guaifenesin (API) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Guaifenesin (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Guaifenesin (API) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Guaifenesin (API) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Guaifenesin (API) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Guaifenesin (API) Sales by Type (2019-2030)
4.1.1 Global Guaifenesin (API) Sales by Type (2019-2024)
4.1.2 Global Guaifenesin (API) Sales by Type (2025-2030)
4.1.3 Global Guaifenesin (API) Sales Market Share by Type (2019-2030)
4.2 Global Guaifenesin (API) Revenue by Type (2019-2030)
4.2.1 Global Guaifenesin (API) Revenue by Type (2019-2024)
4.2.2 Global Guaifenesin (API) Revenue by Type (2025-2030)
4.2.3 Global Guaifenesin (API) Revenue Market Share by Type (2019-2030)
4.3 Global Guaifenesin (API) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Guaifenesin (API) Sales by Application (2019-2030)
5.1.1 Global Guaifenesin (API) Sales by Application (2019-2024)
5.1.2 Global Guaifenesin (API) Sales by Application (2025-2030)
5.1.3 Global Guaifenesin (API) Sales Market Share by Application (2019-2030)
5.2 Global Guaifenesin (API) Revenue by Application (2019-2030)
5.2.1 Global Guaifenesin (API) Revenue by Application (2019-2024)
5.2.2 Global Guaifenesin (API) Revenue by Application (2025-2030)
5.2.3 Global Guaifenesin (API) Revenue Market Share by Application (2019-2030)
5.3 Global Guaifenesin (API) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Granules
6.1.1 Granules Corporation Information
6.1.2 Granules Description and Business Overview
6.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Granules Guaifenesin (API) Product Portfolio
6.1.5 Granules Recent Developments/Updates
6.2 Synthokem Labs
6.2.1 Synthokem Labs Corporation Information
6.2.2 Synthokem Labs Description and Business Overview
6.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Synthokem Labs Guaifenesin (API) Product Portfolio
6.2.5 Synthokem Labs Recent Developments/Updates
6.3 Haizhou Pharma
6.3.1 Haizhou Pharma Corporation Information
6.3.2 Haizhou Pharma Description and Business Overview
6.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Haizhou Pharma Guaifenesin (API) Product Portfolio
6.3.5 Haizhou Pharma Recent Developments/Updates
6.4 Yuan Cheng Group
6.4.1 Yuan Cheng Group Corporation Information
6.4.2 Yuan Cheng Group Description and Business Overview
6.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yuan Cheng Group Guaifenesin (API) Product Portfolio
6.4.5 Yuan Cheng Group Recent Developments/Updates
6.5 Stellar Chemical
6.5.1 Stellar Chemical Corporation Information
6.5.2 Stellar Chemical Description and Business Overview
6.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Stellar Chemical Guaifenesin (API) Product Portfolio
6.5.5 Stellar Chemical Recent Developments/Updates
6.6 Seven Star Pharma
6.6.1 Seven Star Pharma Corporation Information
6.6.2 Seven Star Pharma Description and Business Overview
6.6.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Seven Star Pharma Guaifenesin (API) Product Portfolio
6.6.5 Seven Star Pharma Recent Developments/Updates
6.7 Gennex Lab
6.6.1 Gennex Lab Corporation Information
6.6.2 Gennex Lab Description and Business Overview
6.6.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gennex Lab Guaifenesin (API) Product Portfolio
6.7.5 Gennex Lab Recent Developments/Updates
6.8 Iwaki Seiyaku
6.8.1 Iwaki Seiyaku Corporation Information
6.8.2 Iwaki Seiyaku Description and Business Overview
6.8.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Iwaki Seiyaku Guaifenesin (API) Product Portfolio
6.8.5 Iwaki Seiyaku Recent Developments/Updates
6.9 Pan Drugs
6.9.1 Pan Drugs Corporation Information
6.9.2 Pan Drugs Description and Business Overview
6.9.3 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pan Drugs Guaifenesin (API) Product Portfolio
6.9.5 Pan Drugs Recent Developments/Updates
6.10 Delta Synthetic
6.10.1 Delta Synthetic Corporation Information
6.10.2 Delta Synthetic Description and Business Overview
6.10.3 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Delta Synthetic Guaifenesin (API) Product Portfolio
6.10.5 Delta Synthetic Recent Developments/Updates
6.11 Smart Pharm
6.11.1 Smart Pharm Corporation Information
6.11.2 Smart Pharm Guaifenesin (API) Description and Business Overview
6.11.3 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Smart Pharm Guaifenesin (API) Product Portfolio
6.11.5 Smart Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Guaifenesin (API) Industry Chain Analysis
7.2 Guaifenesin (API) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Guaifenesin (API) Production Mode & Process
7.4 Guaifenesin (API) Sales and Marketing
7.4.1 Guaifenesin (API) Sales Channels
7.4.2 Guaifenesin (API) Distributors
7.5 Guaifenesin (API) Customers
8 Guaifenesin (API) Market Dynamics
8.1 Guaifenesin (API) Industry Trends
8.2 Guaifenesin (API) Market Drivers
8.3 Guaifenesin (API) Market Challenges
8.4 Guaifenesin (API) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
